Vertraagde tijd
Japan Exchange
04:30:00 15-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
15
JPY
|
-6,25%
|
|
-16,67%
|
-34,78%
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
31.465
|
20.192
|
10.933
|
21.689
|
13.292
|
9.054
|
Bedrijfswaarde
1 |
24.725
|
15.335
|
6.220
|
18.790
|
11.456
|
7.937
|
K/w-verhouding
|
-11
x
|
-6,79
x
|
-4,52
x
|
-13,9
x
|
-5,03
x
|
-8,1
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
149
x
|
72,1
x
|
34,6
x
|
65,3
x
|
11,5
x
|
7,98
x
|
Bedrijfswaarde/omzet
|
117
x
|
54,8
x
|
19,7
x
|
56,6
x
|
9,94
x
|
7
x
|
Bedrijfswaarde/EBITDA
|
-8,71
x
|
-5,98
x
|
-2,89
x
|
-11,8
x
|
-5,62
x
|
-7,28
x
|
Bedrijfswaarde/FCF
|
-10,9
x
|
-11,2
x
|
-4,01
x
|
-15,7
x
|
-6,43
x
|
-34,2
x
|
FCF Yield
|
-9,17%
|
-8,93%
|
-24,9%
|
-6,36%
|
-15,6%
|
-2,92%
|
Price to Book
|
4,3
x
|
4,2
x
|
2,31
x
|
7,05
x
|
6,72
x
|
10,6
x
|
Aantal aandelen (in duizenden)
|
147.032
|
149.572
|
176.332
|
176.332
|
192.644
|
192.644
|
Referentieprijs
2 |
214,0
|
135,0
|
62,00
|
123,0
|
69,00
|
47,00
|
Datum van publicatie
|
22/06/18
|
20/06/19
|
24/06/20
|
22/06/21
|
21/06/22
|
27/06/23
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
211
|
280
|
316
|
332
|
1.153
|
1.134
|
EBITDA
1 |
-2.840
|
-2.563
|
-2.150
|
-1.589
|
-2.037
|
-1.091
|
Bedrijfsresultaat (EBIT)
1 |
-2.988
|
-2.954
|
-2.189
|
-1.638
|
-2.053
|
-1.107
|
Operationele Marge
|
-1.416,11%
|
-1.055%
|
-692,72%
|
-493,37%
|
-178,06%
|
-97,62%
|
Resultaat voor belastingen (EBT)
1 |
-2.920
|
-3.192
|
-2.237
|
-1.560
|
-2.570
|
-1.116
|
Nettowinst (verlies)
1 |
-2.851
|
-2.934
|
-2.238
|
-1.561
|
-2.571
|
-1.118
|
Nettomarge
|
-1.351,18%
|
-1.047,86%
|
-708,23%
|
-470,18%
|
-222,98%
|
-98,59%
|
WPA
2 |
-19,39
|
-19,89
|
-13,73
|
-8,853
|
-13,71
|
-5,803
|
Free Cash Flow
1 |
-2.268
|
-1.369
|
-1.551
|
-1.196
|
-1.782
|
-231,9
|
FCF-marge
|
-1.075,12%
|
-489,02%
|
-490,86%
|
-360,17%
|
-154,56%
|
-20,45%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
22/06/18
|
20/06/19
|
24/06/20
|
22/06/21
|
21/06/22
|
27/06/23
|
Fiscaal tijdperk: Maart |
2020 S1
|
2021 S1
|
2022 S1
|
2022 Q3
|
2023 Q1
|
2023 S1
|
2023 Q3
|
2024 Q1
|
2024 S1
|
2024 Q3
|
---|
Omzet
1 |
104
|
100
|
240
|
95
|
385
|
514
|
185
|
148
|
356
|
110
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-1.218
|
-838
|
-948
|
-762
|
-307
|
-618
|
-286
|
-386
|
-694
|
-278
|
Operationele Marge
|
-1.171,15%
|
-838%
|
-395%
|
-802,11%
|
-79,74%
|
-120,23%
|
-154,59%
|
-260,81%
|
-194,94%
|
-252,73%
|
Resultaat voor belastingen (EBT)
1 |
-1.256
|
-755
|
-1.228
|
-909
|
-277
|
-612
|
-299
|
-399
|
-709
|
-276
|
Nettowinst (verlies)
1 |
-1.256
|
-756
|
-1.229
|
-910
|
-277
|
-613
|
-300
|
-400
|
-710
|
-277
|
Nettomarge
|
-1.207,69%
|
-756%
|
-512,08%
|
-957,89%
|
-71,95%
|
-119,26%
|
-162,16%
|
-270,27%
|
-199,44%
|
-251,82%
|
WPA
2 |
-8,010
|
-4,290
|
-6,740
|
-4,780
|
-1,440
|
-3,190
|
-1,550
|
-1,990
|
-3,420
|
-1,260
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
8/11/19
|
6/11/20
|
5/11/21
|
4/02/22
|
5/08/22
|
4/11/22
|
10/02/23
|
10/08/23
|
10/11/23
|
9/02/24
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
6.740
|
4.857
|
4.713
|
2.899
|
1.836
|
1.117
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-2.269
|
-1.369
|
-1.551
|
-1.196
|
-1.782
|
-232
|
ROE (netto-inkomsten/eigen vermogen)
|
-33,1%
|
-51,3%
|
-46,6%
|
-40%
|
-102%
|
-78,9%
|
ROA (netto-inkomsten/totale activa)
|
-20,1%
|
-27,6%
|
-26,2%
|
-24,2%
|
-42,4%
|
-33%
|
Totale activa
1 |
14.208
|
10.638
|
8.551
|
6.447
|
6.064
|
3.390
|
Nettoactief per aandeel
2 |
49,80
|
32,10
|
26,80
|
17,40
|
10,30
|
4,430
|
Cashflow per aandeel
2 |
45,80
|
32,00
|
26,70
|
16,40
|
9,530
|
5,800
|
Capex
1 |
408
|
71
|
130
|
43
|
456
|
4
|
Capex/omzet
|
193,36%
|
25,36%
|
41,14%
|
12,95%
|
39,55%
|
0,35%
|
Datum van publicatie
|
22/06/18
|
20/06/19
|
24/06/20
|
22/06/21
|
21/06/22
|
27/06/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| -34,78% | 22,29 mln. | | +5,33% | 111 mld. | | +12,11% | 105 mld. | | -12,56% | 22,34 mld. | | -3,70% | 21,93 mld. | | -6,03% | 18,59 mld. | | -35,21% | 18,12 mld. | | -10,86% | 16,96 mld. | | +5,10% | 13,7 mld. | | +37,57% | 12,45 mld. |
Biotherapeutische geneesmiddelen
|